DUBLIN , July 7, 2022 /PRNewswire/ -- The "Face Mask Equipment: Global Markets" report has been added to ResearchAndMarkets.com's offering.

The demand for face masks among frontline health professionals (e.g., first responders, nurses, medical practitioners) is fueled by the development of respiratory infection-based pandemic illnesses, such as H1N1 and COVID-19. N95 respirator masks are becoming increasingly popular for protecting healthcare personnel from dangerous viruses and microorganisms. Pandemic diseases such as COVID-19 and H1N1, and other infectious viruses have claimed millions of lives. Social isolation and the use of face masks are the only ways to protect people from contagious viruses. Governments increased production activities to avoid face mask shortages, which has fueled the expansion of the face mask market. The global face mask material market is segmented into cotton, polypropylene and others (e.g., polyurethane, polyester, PET, rubber). In 2021, the polypropylene non-woven fabric segment dominated the market. Polypropylene, one of the major commodity plastic resins, is produced in large quantities in many countries. It can be easily converted into spun-bonded fabric and structured with a wide range of properties, so it is considered a major raw material for face mask production. The global face mask by type market is segmented into surgical, N-series, respirators and others (e.g., dust resistant, procedural masks, fashion masks). In 2021, the surgical masks segment was dominant. These masks are mainly used in healthcare application, but due to the rise in COVID-19 cases, many residential households started using them, leading to an increase in their market share. The global face mask market by usage is segmented into disposable and reusable. In 2021, the reusable mask segment was dominant. Shortages of disposable face masks, affordability and ease of use resulted in massive adoption of reusable face masks. The global face mask market by distribution channel is segmented into online and offline. In 2021, the online sales segment was dominant. In the offline segment, major sales shares were contributed by retailers and convenience stores. The global face mask market by application is segmented into healthcare, personal and industrial. In 2021, the healthcare sector dominated the application market, as it includes the primary users of respirators and surgical masks to prevent the inhalation of bacteria and viruses. Mandatory use of face masks in hospitals and clinics became part of the infection control strategy and helped to reduce cross contamination between patients and nursing staff.

An overview of the global market for face masks equipment

Estimation of the market size and analyses of global market trends, with data from 2021, estimates for 2022, 2023 with projections of compound annual growth rates (CAGRs) through 2027

Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace

Highlights of the current market scenario, recent information, latest developments, and factors impacting the growth of the market

Description of different types of masks including surgical mask and N-series mask (N 95, N 99, etc.) and discussion on awareness of face masks usage due to coronavirus impact

Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market size and forecast, and assessment of new developments in the industry

Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies and a relevant patent analysis

Comprehensive company profiles of the leading players, including 3M , Cardinal Health, Honeywell International and UVEX Group

Key Topics Covered: Chapter 1 Introduction

Chapter 2 Summary and Highlights Chapter 3 Market Overview

Impact of the Coronavirus on the Face Mask Industry

Chapter 4 Market Dynamics and Supply Chain Analysis

Role of Social Media in Increasing the Demand for Masks

Growing Healthcare Industry in Emerging Economies

Development of Face Masks with Advanced Technologies

Volatility in Raw Material Prices

Severe Impact of Face Masks on the Environment

Growing Trends in Health Standards and Occupational Safety

Strong Product Demand from the Healthcare Industry

Growing Adoption of Face Masks in the End-Use Industries

Integration of Technology in Personal Protective Equipment

High Product Prices in the Industrial Sector

Slump in Demand for Personal Protective Equipment Products

Chapter 5 Market for Face Masks by Mask Type

Chapter 6 Market for Face Masks by Material

Chapter 7 Market for Face Masks by Usage

Chapter 8 Market for Face Masks by Distribution Channel

Chapter 9 Market for Face Masks by Application

Chapter 10 Market for Face Masks by Region

For more information about this report visit https://www.researchandmarkets.com/r/sq9n18

Research and Markets Laura Wood , Senior Manager press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/face-mask-equipment-global-market-report-2022-strong-product-demand-from-the-healthcare-industry--growing-adoption-of-face-masks-in-the-end-use-industries-presents-opportunities-301582210.html

As 2023 starts gearing up for the long haul, Wall Street is still taking a bearish view of the markets. We’re still dealing with the same headwinds, a combination of stubbornly high inflation, rapidly rising interest rates, gloomy economic indicators, the continuing war in Ukraine, uncertainty over China’s lockdown policies, a supply chain that is only slowly unsnarling itself… the list can go on. But despite the grim outlook right now, there are still some signals that give reasons for longer-t

No Fed officials thought it’d be appropriate to begin cutting rates in 2023, as members thought that that price pressures could prove to be more persistent than anticipated with the job market remaining so strong for longer than anticipated, according to internal discussions of Fed officials at their policy meeting three weeks ago.

The bear run of 2022 was brutal on stock investors, in fact, it was the worst market year since the Great Recession of 2008. But – some of the Street’s strategists are predicting that this year has a recovery, or at least a partial rebound, in store. Even though the S&P 500 lost nearly 20% last year, inflation is still running at more than 7% annualized, and the Federal Reserve has bumped interest rates up to 4.25% in response, John Stoltzfus, Oppenheimer Asset Management chief investment strate

The On-Balance-Volume (OBV) line shows some slight improvement from late September. The Moving Average Convergence Divergence (MACD) oscillator is bullish. The weekly OBV line has stayed steady but the MACD oscillator is now above the zero line and bullish.

Buffett's company, Berkshire Hathaway, is much more invested in the tech sector than it used to be.

The current rate is good, but if you hold off until just before the next change, it could be even better.

Yahoo Finance Live breaks down analyst concerns in Microsoft's Azure cloud unit, also commenting on the tech company's partnership with ChatGPT.

Yahoo Finance Live anchors discuss GE HealthCare completing its spin-off from General Electric.

The memory giant rose on reports that China may be throwing in the towel on subsidizing competitors.

(Bloomberg) -- Markets aren’t prepared for how far US central bankers are willing to go to tame the hottest inflation in a generation, according to Morgan Stanley Investment Management’s Jim Caron.Most Read from BloombergIf You Have Student Loans, Mark These Dates on Your CalendarWhy Conservatives Are Blocking McCarthy as Speaker — and Throwing Congress Into ChaosNew Hedge Fund Soars 163% Betting It’s All Going DownFed Affirms Inflation Resolve, Pushes Back Against Rate-Cut BetsShopify Tells Emp

The big market headline last year has been the steady fall in stocks. The S&P 500 tumbled 19% for 2022, and the NASDAQ has fallen a disastrous 33%. And while recent data shows that there may be some hope on the inflation front, there may still be storm clouds massing for this year’s stock market. In times like these, it’s natural to turn to the high-yield dividend payers. These stocks offer the twin advantages of a steady income stream through regular, reliable dividend payments – and dividend y

The über-rich are keeping their powder dry in the new year, a poll of ultra-high-net-worth investors found. Then they'll "pounce."

Democrats released six years of Donald Trump’s income-tax returns on Friday, providing further insight into the former president’s tax situation. Trump and his wife, Melania, paid $0 in income taxes for 2020, according to a report released late Tuesday by the congressional Joint Committee on Taxation. The nonpartisan committee’s findings also raised several red flags related to the filings, namely Trump’s carryover losses, loans to his children that may or may not also be considered taxable gifts, and deduction-related tax write-offs.

Microsoft stock is down more than 5% following a downgrade from UBS. Is it a buying opportunity or are still lower prices in store?

For Citi customers with a sizable sum on hand, opening a new savings account can deliver just that — but, of course, not without significant hurdles. Like many bank accounts these days, the Citi® Savings Account comes with the promise of a hefty sign-up bonus — up to $3,500 — for simply opening a new account and “completing required activities.” Chanelle Bessette, banking specialist at NerdWallet, says offerings like these, albeit eye-catching at first glance, show just why it’s critical to read the fine print.

After releasing topline late-stage clinical trial data on its drugs effect on a set of precancerous conditions, a longtime Bay Area biotech said it plans to raise $175 million through a stock sale. Geron Corp. (NASDAQ: GERN) said early Wednesday that its drug, called imetelstat, met the primary efficacy goal in a Phase III study in certain patients with myelodysplastic syndromes, or MDS. The company said it will submit the data to the Food and Drug Administration as it asks the agency this year to approve the drug.

'Because of the 2.5% rate, none of us are interested in selling the house and getting our rates jacked up to 7%.'

The deal comes shortly after Boeing lost its bid for a contract that would have been worth billions of dollars to the aerospace company and driven significant growth at the Ridley Park campus.

(Bloomberg) -- Sim Wong Hoo, who founded Creative Technology Ltd. in Singapore before sparring with Apple Inc., has died. He was 67.Most Read from BloombergIf You Have Student Loans, Mark These Dates on Your CalendarWhy Conservatives Are Blocking McCarthy as Speaker — and Throwing Congress Into ChaosNew Hedge Fund Soars 163% Betting It’s All Going DownFed Affirms Inflation Resolve, Pushes Back Against Rate-Cut BetsShopify Tells Employees to Just Say No to MeetingsSim died peacefully on Jan. 4, t

(Bloomberg) -- Amazon.com Inc. is laying off more than 18,000 employees — the biggest reduction in its history — in the latest sign that a tech-industry slump is deepening.Most Read from BloombergIf You Have Student Loans, Mark These Dates on Your CalendarWhy Conservatives Are Blocking McCarthy as Speaker — and Throwing Congress Into ChaosNew Hedge Fund Soars 163% Betting It’s All Going DownFed Affirms Inflation Resolve, Pushes Back Against Rate-Cut BetsShopify Tells Employees to Just Say No to